Ph1


Also found in: Acronyms.

Ph1

Abbreviation for Philadelphia chromosome.
References in periodicals archive ?
The company also recently presented a case study of a healthy human with mutations in the HAO1 gene, a validated target for the treatment of PH1, as well as results from research on the diagnostic journey of PH1 at the 56th Congress of the European Renal Association and European Dialysis and Transplant Association held on June 13-16, 2019 in Budapest, Hungary.
The majority of transplants were for PH1 (n=52, 48.6%), ARPKD (n=20, 18.5%) and atypical factor H deficiency (n=8, 7.4%).
Professional astronomers have since confirmed the existence of PH1 and its four suns, but Jek and Gagliano are credited with the find.
Age at Urinary Age at first oxalate, inclusion, symptoms, mmol/mol Patient years years Symptoms creatinine (a) 1 59 2 UNI (b) 60 2 85 34 U 80 3 55 51 UNR 70 4 40 31 UNR 200 5 63 48 UI 130 6 69 50 UE 100 Patient Comorbidity Diagnosis 1 PH1 2 IH 3 Sb SH 4 Cd SH 5 Sb,Cd SH 6 Sb SH (a) Reference value, 0-54 mmol/mol creatinine.
PH2 through PH7 were developed using the same breeding scheme as PH1, except for the use of different wild species for each germplasm.
Dicerna recently announced initiation of participant screening in the PHYOX2 trial, which will evaluate a multi-dose regimen of DCR-PHXC in individuals with PH1 and PH2.
Primary hyperoxaluria type 1 (PH1) [1] (OMIM 259900) is an autosomal recessive disorder of glyoxylate metabolism caused by deficiency of alanine:glyoxylate aminotransferase (AGT; EC 2.6.1.44).
THE CHINESE SPRING ph1b mutant, a deletion of the Ph1 gene (pairing homoeologous) promotes homoeologous chromosome pairing at meiosis metaphase I (MI) between common wheat and its relatives (Sears, 1977).
"Syracuse teaches you to look beyond your horizons and be more creative, unlike most Navy schools that teach you the technical side," said PH1 Steve Vanderwerff, a Syracuse graduate from the Motion Media Specialist Program in 1996.
The update reflects agreement on the primary endpoint for the PHYOX 2 pivotal clinical trial, which is enrolling patients with PH type 1, or PH1, and PH type 2, or PH2, and alignment with the FDA regarding the path to full approval for the treatment of patients with PH1, as conveyed during a recent FDA Type A meeting.
The study will enroll approximately eight patients with PH1 under six years of age.
The product is intended to treat primary hyperoxaluria type 1 (PH1), which is a rare, inherited disorder of the liver that leads to kidney failure.